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The phospholipase C (PLC)- mediated hydrolysis of mem-
brane phosphoinositides is an important signal transduction 
pathway coupled to the cell-surface receptors for several hor-
mones and growth factors. In addition, PLC activity can be 
modulated by changes in intracellular calcium and activation 
of GTP binding proteins. In this. report, diffe~ential activa-
tion of PLC in the human keratmocyte cell lme SCC-12F 
was studied as judged by specific patterns of inositol phos-
phate formation. Sev~ral hormon~s and . growth factors 
previously shown to stimulate PLC m a vanety of cell types 
were screened for activity in SCC-12F cells. Only bradykinin 
was active, stimulating the PLC-dependent generation of 
inositol (1,4,5) triphosphate (Ins(1,4,5)P3 ). Ins(1,4,5)P:~ was 
rapidly metabolized to inositol( 1,4 )biphosphate (Ins( 1,4 )P 2 ) 
and inositol(l,3,4,5)tetrakisphosphate (Ins(l ,3,4,5)P 4 ), and 
subsequently degraded to inositol monophosphates. There-
T he actions of certain hormones and growth factors on target cells are mediated by specific cell-surface recep-tors. Binding of these agents to their cognate recep-tors can activate various signal transduction pathways, including the phospholipase C (PLC)-mediated hy-
drolysis of PtdlnsP2 to the second messengers lns(1,4,5)P3 and sn-
1,2-diacylglycerol (DAG). DAG remains in the plasma membrane 
and acts as the endogenous activator of protein kinase C (PKC), 
which in turn phosphorylates specific proteins. Ins(l ,4,5)P3 is re-
leased into the cytosol and mobilizes ca++ from intracellular storage 
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Abbreviations: 
BSA: bovine serum albumin 
DAG: sn-1,2-diacylglycerol 
DMEM: Dulbecco's minimal essential medium 
DMSO: dimethyl sulfoxide 
EC50 : concentration of agent producing 50% of the maximal response 
EDT A: ethylenediaminetetraacetic acid 
EGF: epidermal growth factor 
EGTA: ethylenebis (oxyethylenenitrilo}-tetraacetic acid 
FCS: fetal calf serum 
GTP: guanosinetriphosphate 
HBSS: Hank's balanced salt solution 
sponse elicited by bradykinin was concentration dependent 
(EC50 value of 50 nM), suggesting involvement of a specific 
bradykinin receptor. Treatment of these cells with the cal-
cium ionophore A23187 appeared to result in the direct for-
mation of Ins(1,4)P2 without Ins(1,4,5)P3 as precursor. 
Treatment of the cells with AIF4-, a putative activator of 
GTP binding proteins, resulted in the generation of inositol 
monophosphates as the major metabolites in the absence of 
detectable Ins(1,4,5)P3 formation. Taken together, these ob-
servations suggest that the PLC complex present in SCC-12F 
cells can be differentially activated to yield either 
Ins(1,4,5)P3 , Ins(1,4)P2 , or InsP. The observed effects may 
be due to a direct PLC-dependent hydrolysis of the appropri-
ate membrane phosphoinositide. J Invest Dermatol 96:116-
122, 1991 
sites. The Ins(1 ,4,5)Prmediated Ca++ signal results in the activa-
tion of calmodulin-dependent protein kinases and several othet 
Ca++-dependent protein kinases and enzymes (reviewed in [1-4}). 
An additional route oflns(1,4,5)P3 metabolism is its conversion to 
inositol(1,3,4,5)-tetrakisphosphate (Ins(1,3,4,5)P4 ), which re-
cently has been proposed to regulate calcium entry from the extra-
cellular space (5 J. 
The phosphatidylinositol (PI) signal transduction pathway is in. 
volved in the control of cell-specificJhysiologic processes such as 
neuronal excitability, contraction, an secretion. Growth factor- or 
HEPES: 4-(2-hydroxyethyl)-1-piperazineethansulfonic acid 
HPLC: high-performance liquid chromatography 
5-HT: 5-hydroxytryptamine 
lnsP: inositolmonophosphate 
Ins(1,4}P2 : inositol (1 ,4)biphosphate 
Ins(1,4,5}P3 : inositol (1 ,4,5}triphosphate 
lnsP 3 : inositoltriphosphate 
Ins(1,3,4,5)P 4 : inositol (1 ,3,4,5}tetrakispl10sphate 
PBS: phosphate-buffered saline 
PDGF: platelet-derived growth factor 
PLC: phospholipase C 
Ptdlns: phosphatidylinositol 
PtdlnsP: phosphatidylinositol phosphate 
PtdlnsP 2 : phosphatidylinositol hi phosphate 
PKC: protein kinase C 
TCA: trichloroacetic acid 
TGF: transforming growth factor 
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mitogen-induced hydrolysis of phosphoinositides results in a Ca++ 
signal and the activation of specific protein kinases proposed to be 
involved in the initiation of DNA synthesis and cell proliferation 
[3]. In contrast, increases in intracellular Ca++ play an important 
role in terminal differentiation of keratinocytes (6]. The mecha-
nisms for the apparent paradox in the biologic actions of intracellu-
lar ca++ are poorly understood. 
Although the PI signal transduction pathway has been exten-
sively studied in a variety of cell models, there are relatively few 
reports characterizing this system in keratinocyte cell systems. 
Jaken and Yuspa observed a sustained formation of inositol phos-
phates in murine keratinocytes treated with the calcium ionophore 
A;23187 (7]. In a closely related study, Tang eta! reported an en-
hanced formation of inositol phosphates in murine keratinocytes 
associated with increased extracellular Ca++ concentration and hy-
pothesized that inositol phosphate formation played a role in ini-
tiating keratinocyte differentiation (8]. 
In the present study, the PI signal transduction pathway was 
characterized in the squamous cell carcinoma line SCC-12F. The 
SCC-12F cell line is clonally derived from a facial tumor and is 
phenotypically similar to normal human keratinocytes with regard 
to growth and differentiation in culture (9,10]. Thus, SCC-12F 
cells provide a human epithelial cell model for elucidation of the 
role of the PI signal transduction pathway in the regulation of 
growth and differentiation. Three potential modes of activation of 
the PI signal transduction pathway were characterized: cell surface 
receptor coupling to PLC, modulation of PLC activity by changes 
in intracellular Ca++ concentration, and activation ofPLC-coupled 
GTP-binding proteins. 
MATERIALS AND METHODS 
Cell Culture Stock cultures of SCC-12F cells (kindly provided 
by Dr. James G. Rheinwald, Dana-Farber Cancer Research Insti-
tute, Boston, MA) were grown on a mitomycin C (Sigma, St. Louis, 
MO) -treated feeder layer of murine 3T3 cells (ATCC, Rockville, 
MD) in DMEM (Gibco, Grand Island , NY) supplemented with 5% 
fetal calf serum (FCS) (Hyclone, Logan, UT), 4 m.M glutamine 
(Gibco, Grand Island, NY), and 0.5 mM sodium pyruvate (Sigma). 
Confluent stock cultures were washed with 0.02% EDT A in phos-
phate-buffered saline (PBS, Ca++ and Mg++ free), disaggregated 
with 0.1 % trypsin (Gibco) in the same PBS/EDTA buffer and pas-
saged without 3T3 cells at a density of 1-2 X 104 cells/cm2 in 
35-mm 6-well plates. The medium was changed every third day. At 
confluency (typically 7 dafter passaging), the SCC-12F cells were 
labeled by incubating for 48 h with culture media containing 2.5 
JlCijml myo(2-3H) inositol (Amersham, Arlington Heights, IL) 
and 0.1% DMSO (Baker, Phillipsburg, NJ). 
Cell Stimulation Prior to stimulation, the labeled SCC-12F 
cells were washed twice with PBS (3rC), followed by an incuba-
tion at 3rC in Hank's balanced salt solution (HBSS) (Gibco) buf-
fered with 10 mM HEPES (pH 7.4) and supplemented with 10 mM 
LiCl (Sigma). LiCl has been shown to block the degradation of 
inosirol monophosphates (InsP) to inositol (11, 12). Thus, in the 
presence of LiCl, InsP accumulation provides a measure for the 
activation of the phosphatidylinositol metabolic pathway. After 30 
min, the HBSS was aspirated and the cells were treated with various 
activators of PLC dissolved in the 10 mM LiCl-supplemented 
HESS. The Ca-ionophore A23187, bradykinin, L-epinephrine, 
histamine, and 5-hydroxytryptamine (5-HT) , were purchased from 
Calbiochem (San Diego, CA). Platelet-derived growth factor 
(PDGF) and transforming growth factor Pt (TGFP1 ) were pur-
chased from R & D Systems (Minneapolis MN). TGFa and EGF 
were purchased from BTI (Stoughton, MA). Stock solutions of all 
the potential activators of PLC examined (except the growth fac-
tors) were made up in DMSO. Stock solutions of the growth factors 
were prepared in 4 nM HCI containing 1 mg/ml BSA. Appropriate 
volumes of both solvents served as vehicle controls. The cells were 
incubated with a given PLC activator at 37"C for various time 
periods. At the end of the incubation period, the supernatant was 
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Figure 1. Separation of (3H)inositol phosphates by HPLC. [JH)lnositol 
phosphates were separated by anion-exchange HPLC using a Partisil SAX 
10 column and an ammomum phosphate gradient as described in Materials 
a11d Merlzods. A, representative elution profile of(3H]inositol phosphate stan-
dards. 1, Ins; 2, Ins(!)P; 3, Ins(1,4)P2; 4, Ins(1,4,S)P3 ; 5, Ins(1,3,4,S)P4 . A 
typical elution profile of (3H)inosirol phosphates isolated from SCC-12F 
cells treated with bradykinin is shown in B. (3H)myo-inositol prelabeled 
cells were tt·eated with a pM bradykinin for 1 min in the presence of10 mM 
LiCI. The TCA-extracted inositol phosphates were separated by HPLC. 
Retention times for ['H]inositol phos~hate standards are indicated by arrows. 
From comparable HPLC techntques [14, 15], the peaks designated X andY 
are thought to represent Ins(4)P and Ins(1 ,3,4)P3 , respectively. 
aspirated and 1 ml of ice-cold 18% trichloroacetic acid (TCA) con-
taining 250 JiM phytic acid hydrolysate (Sigma) was added. The 
phytic acid hydrolysate enhanced the recovery of higher charged 
inositol phosphates, especially oflns(1,3,4,5)P4 [13]. The cells were 
incubated for 30 min at 4 oc with the TCA solution to extract 
inositol phosphates. The TCA supernatants were extracted three 
times with 5 vol water-saturated diethylether and the aqueous phase 
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Table I. Comparison of the Accumulation of [3H]lnositol Monophosphates in SCC-12F Cells Activated by Various Neurotransmitters, 
Growth Factors, and Other Agents• 
Number of Vehicle Control Treatment Percent Agonist 
Assays (JH]lnsP/Well in cpm ['H]lnsP /Well in cpm of Control 
Bradykinin (1 ,uM) 6 4841 ± 652• 11145 ± 4580b 230 
5-HT (l,uM) 5 4887 ± 520 3344 ± 712b 68 
Histamine (1,UM) 5 4887 ± 520 4211 ±882 86 
Epinephrine (1 ,uM) 5 4887 ± 520 4036 ± 731 82 
EGF (O.l,uM) 6 5030 ± 949 5316 ± 1144 105 
PDGF (10 ng/ml) 4 4298 ± 1133 3716 ± 902 86 
TGFa (10 ng/ml) 4 4298 ± 1133 3590 ± 716 83 
TGF/31 (10 ng/ml) 4 4298 ± 1133 3400 ± 354 79 
A23187 (10 ,uM) 4 4257 ± 497 7832 ± 1868b 184 
Naf (20 mM), 9 5519 ± 1367 15148 ± 3366b 274 
AICl3 (lO,uM) 
• Confluent cultures of [>H]inositol-_labeled SCC-12F cells were treated with the compounds indicated for 30 min in the presence of 10 mM lithium ch loride. [>H]inositol 
monophosphates were assayed as deserted 111 Matenals a11d Metlwds. The values shown represent the means± SD from rwo to four independent experiments. 
• Significantly di/ferenr from control (p < 0.05, unpooled vanance t rest). 
was then adjusted to a neutral pH with 1.5 M NH40H. After evapo-
ration in a vacuum centrifuge (Savant, Hicksville, NY), the samples 
were taken up in 500 ,ul deionized water, adjusted to a neutral pH 
with 1.5 M NH40H, and stored at- 20oC for up to 3 weeks prior 
to analysis. 
Analysis of Inositol Phosphates by HPLC The samples con-
taining the inositol phosphate metabolites were centrifuged in a 
microfuge (Beckmann, Palo Alto, CA) for 2 min at 11,600 X g. 
Separation of inositol phosphates was achieved by means of anion 
exchange chromatography. The HPLC system, consisting of a 
Spectroflow 400 pump and Spectroflow 430 gradient former, was 
purchased from Kratos (Ramsey, NJ). The HPLC anion-guard col-
umn was purchased from Waters (Milford, MA) and the precolumn 
was purchased from Whatman (Fairfield, NJ). The samples were 
separated on a Partisil SAX 10 column (Whatman) with a flow rate 
of 1 ml/min using H 20 as eluant for the first 15 min, followed by a 
linear gradient to 1. 9 M NH4H 2P04 , pH 4.0, over 35 min . For the 
last 20 min, the column was developed with 1.9 M NH4H2P04 
alone (modified after [ 14, 15]). 
Radioactivity was monitored on-line with a Flo-one CT -/3 detec-
tor (Radiomatic, Tampa, FL). Picoflow IV (Packard, Downers 
Grove, IL) was used as scintillant and added at a ratio of 3: 1 to the 
eluent. The integrated peak areas for each metabolite were mea-
sured in cpm with a counting efficiency of 36%, which did not 
change during the entire gradient program. The minimum detec-
tion limit per peak was set to 150 cpm. Authentic tritiated inositol 
phosphate standards were purchased from Amersham (Arlington 
Heights, IL) and the retention times were determined as follows: 
inositol, 4.1 ± 0.1 min; inositol 1-monophosphate (Ins(1)P), 
29.4 ± 0.8 min; inositol 1,4-biphosphate (Ins(1,4)P2 ) , 36.6 ± 0.6 
min; inositol 1 ,4,5-triphosphate (Ins(l ,4,5)P3), 45.3 ± 0.3 min; in-
ositol 1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4 ) , 53.4 ± 0.5 min 
(mean± SD; n = 6). 
RESULTS 
Identification of Inositol Phosphates Radioactive peaks were 
identified by comparison of their retention times with those of 
authentic (3H) standards. A HPLC elution profile of four inositol-
phosphate standards is shown in Fig 1A. In Fig 1B, a representative 
HPLC chromatogram of a sample prepared with (3H)inositol-la-
beled SCC-12F cells stimulated with 1jJ.M bradykinin for 1 min is 
shown. In addition to the four standards, we observed two unidenti-
fied peaks designated as X andY. Based on the elution characteris-
tics in comparison to the similar HPLC method of Dean and Moyer 
[14, 15]. these metabolites are most likely to be Ins(4)P (X) and 
lns(1,3,4)P3 (Y) . This assumption is supported by the observation 
that peak Y appeared after an increase in the tetrakisphosphate 
Ins( 1 ,3,4,5)P 4 , indicating that Y might indeed represent the tri-
phosphate degradation product of Ins(l,3,4,5)P4. Because the 
HPLC gradient conditions used allowed no baseline separation be-
tween lns(l )P and the second metabolite (X), radioactivity in this 
area of the chromatogram is referred to as InsP. 
Receptor-Coupled Activation ofPLC Several hormones and 
growth factors known to activate PLC through coupled membrane 
receptors were screened for activity in SCC-12F cells (Table I). 
Activation ofPLC was assessed by the accumulation oflnsP metabo-
lites in [3H]inositol-labeled cells in the presence ofLiCl (see Materi-
als and Methods). Of the hormones examined, only bradykinin acti-
vated P_LC (appr~ximately 2.3 times at a concentration of 1 ,uM). 
H1stamme and epmephrine were inactive, whereas treatment with 1 
,uM 5-HT resulted in a decrease in InsP accumulation (68% of 
control). The growth factors EGF, PDGF, TGFa, and TGF/31 did 
not activate PLC in SCC-12F cells at concentrations shown to be 
active in other systems. 
. Sp:cific inosit~l phosphate metabolic pathways were character-
IZed 111 bradykmm-stlmulated SCC-12F cells. Addition of 1 f.l.M 
b_radykinin to (3H) inositol-labeled cells resulted in a rapid genera-
tion of lns(1 ,4,5)P3, detectable within 5 sec after stimulation and 
r~aching a maximum level within 30 sec (Fig 2A). A second metabo-
lite, Ins(1 ,3,~,5)~ 4, was detected immediately after (between 30 and 
60 sec) the mos1tol tnphosphate (Fig 2B). After 2 min, only low 
amounts of lns(1,4,5)P3 were detected and were comparable to 
those observe_d under basal conditions (Fig 2A). Ins(1,4)P2 was 
formed comc1~en~ w1th the decrease in Ins(1 ,4,5)P3 (Fig 2A,C) . 
The le~el of tillS btphosphate remained elevated up to 10 min after 
bradyku~m trea~ment (Fig 2C). The inositol monophosphates in-
creased lmearly 111 the first ·5 min and remained at this level for up to 
3? T?in (Fig 2D) . Taken together these fin,dings suggest that brady-
kmm stlmul~tes ~he formation of Ins(1,4,5)P3 from PtdinsP2 • 
Ins(1,4,5)P3 ts raptdly metabolized to Ins (1,4)P2 , which is subse-
quently degraded to the inositol monophosphates. To a lesser ex-
tent, Ins(1,4,5)P3 Is converted to Ins(1,3,4,5)P4 (Fig 2A,B). The 
bradybmn-dependent stimulation of Ins(1,4,5)P3 formation was concentra~ion depende_nt, with a_n EC50 value of approximately 
50 nM (Fig 3), suggestmg that thts response is receptor mediated. 
Calcium-Dependent Activation ofPLC In order to character-
ize the calcium-dependent regulation ofPLC in SCC-12F cells, the 
concentratio? of ~ree intracellular Ca++ was increased by treatment 
With the calcmm 10nophore A23187. The time course for the gener-
ation of the mos1tol phosphates in the SCC-12F cells after addition 
of 10 .uM A23187 is shown in Fig 4. In contrast to the results 
obtained following bradykinin stimulation (Fig 3A,B), no change 
was observed in the levels of Ins(1,4,5)P3 or Ins(1,3,4,5)P4 com-
pared to vehicle controls (data not shown). However, the formation 
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Figure 2. Time course of inos itol phosphate formation in SCC-12F cells following stimulation with 1 f!M bradykinin. SCC-1 2F cells were labeled with 2.5 
,uCi/ml (3H)inosito l for 48 h. Incubations with 1 f!M bradykinin (e ) and vehicle contro l (0) were performed for 5 sec-30 min in 10 mM LiC l-supplemented 
HBSS. [3H]inositol phosphates were analyzed as described in Materials a11d Methods. T he results are expressed in cpm and each data point represents the 
mean± SEM of fi ve observations fro m three independent experiments. A , the resul ts fo r Ins (1 ,4,5)P3; B, for Ins(1,3,4,5)P4 ; C, for Ins(1 ,4)P2 ; D, fo r InsP. The 
inset inC represents the early timepoints of Ins( t ,4)P2 fo rmation. 
of lns(1 ,4)P2 increased within 2 min of ionophore stimulation and 
reached its highest level after 30 min, the longest ti me period exam-
ined (Fig 4A ). InsP formation increased in the ionophore-s timu-
lated cell s after 5 min and remained elevated for at least 30 min (Fig 
4B) , at levels comparable to those observed in the bradykinin-
treated cell s (Fig 2D). 
To determine whether the absence oflns(1,4,5)P3 generation was 
due to a non-optimal concentration of A23187, several concentra-
tions of this ionophore (ranging from 1 nM-10 ,uM) were tested in 
cells stimulated for 30 sec. Under these conditions, no Ins(l ,4,5)P3 
was generated (data not shown). Further, there was no change in the 
amount of lns(l ,4,5)P3 formed in cel ls treated with 10 ,uM brady-
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Figure 3. Dose-response curve for the bradykinin-dependent generation of 
lns(1 ,4,5)P3 in SCC-1 2F cells. (3H]Myo-inositol - prclabeled cells were 
treated for 30 sec with bradykinin (e ) in the presence of 10 mM LiC I. 
Results are expressed in cpm and each poi I'l l represents the mean ± SEM of 
two independent experiments perfo rmed in duplicate. 
kinin together w ith A231 87 (1 nM - 10 ,uM), indicating that 
A23187 did not stimulate InsP3 phosphatase, which converts Ins 
(1,4,5)P3 to Ins(1 ,4)P2 • 
T hese findin gs suggest chat calcium ionophore stimulation acti-
vates the formation oflns(l ,4 )P 2 from its Ptdlns precursor by PLC. 
In contrast to the trans ient production of lns(1 ,4)P2 from the degra-
dation of Ins(l ,4,5)P3 in bradykinin-stimulated cells, the levels of 
Ins(1 ,4)P2 remain elevated in cells trea ted with calcium ionophore. 
T he kinetics of the production of the inositol monophosphates sug-
gest that these metabolites result from the degradation of 
Ins(1,4)P2 • 
Fluoride-Mediated Activation of PLC The available experi-
mental evidence suggests that the coupling of cell-surface receptors 
to PLC is mediated by G proteins that become activated by binding 
GT P. G proteins are ac tivated in vitro by sodium fluoride and alumi-
num chloride. Together, these inorganic salts are thought to fo rm 
the anion complex AIF4-, which activates G proteins by mimicking 
the third phosphate gro up on GDP bound to G proteins [1 6 - 18]. 
SCC-12F cells were treated with 20 mM sodium flu oride and 
10 ,uM aluminum chloride. As was observed following treatment 
with the calcium ionophore, there was no increase in Ins (1 ,4,5)P3 
formation. After 20 min, formation of both Ins(1 ,4)P2 and InsP 
were increased compared to vehicle controls (Fig 5A,B). T he pro-
duction of these inositol phosphates continued to increase in the 
treated cells fo r up to 30 min, the longest time point examined. T he 
levels ofinsP observed in the fluoride-stimulated cells were approxi-
mately 2 times higher than those detected in the ionophore-stimu-
lated cells (Figs 4B and SB). Treating cells with NaF at concentra-
tions ranging from 1-50 mM together with 10 ,uM AI C13 for 30 
sec also did not result in the formation of detectable Ins (1 ,4,5)P3 (data not shown) . 
These findings suggest that stimulation with AlF 4- (and presum-
ably activation of G proteins) results in the increased formation of 
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Figure 4. Time course of inositol formation in SCC-1 2F cells treated with 
10 ).lM A23187. ['H]myo-inositol - prelabele'd cells were treated with 
10 ).lM A23 187 (e) or vehicle control (0 ) for 5 sec - 30 min in the presence 
of 10 mM L1C I. The results ~e expressed in cpm and the data represent the 
average± range for an expenment performed in duplicate. A , Ins(1,4)P2 ; B, 
InsP. 
both Ins(1,4)P2 and lnsP from their respective Ptdlns precursors by 
PLC. ln addition, formation of InsP may result in part from the 
degradation of Ins (1,4)P2 • 
DISCUSSION 
In this study, the PI signal transduction pathway was characterized 
in the human squamous cell carcinoma line SCC-12F. Several hor-
mones and growth factors reported to activate the PLC-mediated 
hydrolysis of membrane phosphoinositides in other cell model sys-
tem.s [1 9- 25] were examined for activity in SCC-12F cells (Table 
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Figure 5. Time course of inositol phosphate format ion in SCC-12F cells 
following treatment with 20 mM NaF and 10jlM AICI3 • SCC-12F cells 
were prclabeled for 48 h wi th [JH]myo-inositol. Cells were treated with 
20 mM NaF and 10 jlM AICI 3 (e) or vehicle control (0) for 5 sec - 30 min in 
the presence of 10 mM Li CI. The formation of (3H]inositol phosphates was 
measured as described in Materials atld Methods (A, lns(1,4)P2 ; B, InsP). 
Results are expressed in cpm and data points represent the means ± SEM of 
six observations from three independent experiments. 
I). Only bradykinin was found to be active, st imulating the PLC-
dependent hydrolysis of PtdinsP2 to Ins(1,4,5)P3 (Fig 2A). The 
kinetics for the formation and metabolism of lns(1,4,5)P3 in brady-
kinin-treated SCC-12F cells (Fig 2) were comparable to results 
obtained in a variety of cell types, including the neuronal cell line 
NG 115-401L (26], Rat-1 fibroblas ts (27], and the human epider-
moid carcinoma line A431 [28] . Although SCC-12F cel ls possess a 
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functional EGF receptor (29], this receptor is apparently not linked 
to PLC and thus exerts its function through other signal transduc-
tion pathways, e.g ., its intrinsic tyrosine kinase activity . The inabil-
ity of the other hormones and growth factors examined to activate 
PLC also may result from activation of other signal transduction 
systems. Alternatively, SCC-12F cells may not express the cognate 
receptors for these agents. 
Bradykinin is a potent stimulator of pain and is generated when-
ever cellular injury occurs [30). The observed activation by brady-
kinin of the PI signal transduction pathway in SCC-12F cells (Table 
I, Fig 2) suggests that this agent may provide a signal for increased 
cell proliferation (3]. Thus, one might hypothesize that in addition 
to pain mediation, bradykinin, released in trauma and injury, 
can play a major role in tissue repair and wound heal ing in the 
epidermis. 
PLC can be activated directly by Ca++ to hydrolyze PtdinsP2 , 
PtdinsP, or Ptdins (11] . Studies in isolated membrane systems indi-
cate that both the rate of hydrolysis and the substrate specificity are 
dependent on the calcium concentration (31]. The K, for the hy-
drolysis of Ptdins was estimated to be 1,uM Ca++ (31 ]. In contrast, 
hydrolysis ofPtdinsP2 occurs even in the presence ofEGTA [32]. 
T hese findings indicate a minimal requirement for calcium for the 
hydrolysis of PtdinsP 2 , but high levels of Ca++ are needed for the 
hydrol ysis of PtdinsP and Ptdins. 
Treatment of SCC-12F cells with the calcium ionophore 
A23187 resu lts in the sustained ge neration of Ins(1,4)P2 without 
detectable increases in the levels of Ins(1,4,5)P3 , the precursor to 
Ins(l ,4)P2 (Fig 4A). These findings suggest that an increase in intra-
cellular calcium concentration could result in the preferential hy-
drolysis of PtdinsP relative to PtdinsP2 • A similar mechanism has 
been postulated to occur in GH3 pitui tary cells treated with either 
A23187 or thyrotropin-releasing hormone (33]. In contrast, in 
murine keratinocytes, Tang et al (8] observed an increase in InsP3 
formation fo llowing a switch from low-calcium to high-calcium 
medium, and Jaken and Yuspa (7] reported a sustained increase in 
InsP3 format ion in A23187-treated cells. In culture, human and 
murine keratinocytes differ with respect to the calcium-dependent 
regu lation of proliferation and differentiation (6,34]. These cal-
cium-dependent differences in growth and differentiation could 
result in part from differential calcium dependency ofPLC activity 
and substrate specifity. 
AIF4- has been proposed to activate G proteins coupled to PLC. 
In hepatocytes [1 8j, adrenal glomerulosa cells [35), and in isolated 
rat cerebral membrane preparations (1 7], treatment with AlF4 - re-
sults in increased formation of Ins(1 ,4,5)P3 . In contrast, in SCC-
12F ce ll s, AlF4- treatment resulted in a minor increase in the levels 
of Ins(1,4)P2 and a major increase in InsP. Ins(1 ,4,5)P3 was not 
detected. The relat ive levels o~ the bi- and mono-inositol phos-
phates in AlF4--treated ce lls dtffer marked ly from the levels ob-
served in SCC-12F cells treated with bradykinin or A23187 (Figs 
2,4,and 5). These findin gs suggest that AlF4- may stimulate the 
hydrolysis of PtdinsP to Ins(1,4)P2 , but to a lesser extent than was 
observed fo llowing treatment with A23187 (Figs 4A and SA). The 
formation of InsP could resu lt di rectly from the hydrolys is of 
PtdinsP and, in addition, from the metabolism of Ins(1,4)P2 • The 
lag phase in this response (Fig 5) of 20 min implicates a secondary 
phenomenon . 
In conclusion, these studies provide a basic characterization of the 
PI signal transduction pathway in SCC-12F cells. SCC-12F cells 
possess a functional PI signal transduction system that can be acti-
vated by external cell stimuli, increases in intracellular calcium con-
centration, and activation of GTP binding proteins. The differential 
pathways of inositol phosphate formation observed could result 
from either different modes of activation ofPLC or from the poten-
cial contribution of different isozymes of PLC. 
We wish to express our tha11ks to Dr.J.G. Rl.eitllvaldfor pro1Jidi11g the SCC-12F 
cells a11d Dr. K. Ga ida for supplyi11g stock w ltu re plates of SCC-12F cells. 
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